艾昆纬：2000-2022年药品支出动态：基于场景的医药与医疗支出解读报告（英文版）（18页）.pdf

1、OCTOBER202 5Understanding Medicine and Healthcare Spending in ContextDrug Expenditure Dynamics 20002022The level of drug expenditure is a closely watched,often commented upon,metric that has faced increased scrutiny by policymakers and other stakeholders in recent times.Issues such as global trade b

2、alances,medicine pricing,and international investment decisions are top priorities for countries and pharmaceutical companies alike,leading to a renewed interest in the level of spending on drugs globally.Despite this,the composition of that expenditure and its dynamics are not well understood.Typic

3、ally,official statistics of drug spending only include drugs dispensed in pharmacies and do not include drugs used in hospitals,an issue which raises questions about their representativeness of total drug spending.In October 2021,the IQVIA Institute published a report titled Drug Expenditure Dynamic

4、s 19952020 with estimates of total drug spending,including hospitals and net of discounts and rebates paid by pharmaceutical companies.i Almost four years on from the original publication,an update of the core analyses has been conducted to provide an improved picture beyond publicly reported data.T

5、he latest findings build upon previous analyses,enhance and revise the methodologies,and further illustrate the complexities of comparing systems.The report focuses on a subset of specific countries to enable greater granularity and have included a robust appendix of analyses for each country.The re

6、search for this report was undertaken independently by the IQVIA Institute with the support of the Association of the British Pharmaceutical Industry(ABPI).The contributions to this report of Tanya Bhardwaj,Urvashi Porwal,Vibhu Tewary and dozens of others at IQVIA are gratefully acknowledged.Find Ou